Insulet is continuing the development of Omnipod 6, its next-generation tubeless automated insulin delivery system. On November 4, 2026, the company announced that enrollment of participants with type 1 diabetes in the STRIVE2 clinical trial had been completed. This is an important development milestone for a system currently targeted for launch in 2027.
How Will Omnipod 6 Differ From Omnipod 5?
Omnipod 6 builds on the existing Omnipod technology with improvements intended to make automated insulin delivery more personalized and easier to manage.
Insulet's development goals include:
- a more advanced algorithm for automated insulin delivery and glucose management;
- fewer manual actions required from users;
- improved app controls and device connectivity;
- more flexible integration with compatible CGM sensors.
Final specifications and available features remain subject to development and regulatory requirements.
What Have Clinical Trials Shown?
In June 2026, Insulet presented results from the STRIVE clinical trial involving 132 participants with type 1 or type 2 diabetes.
Among participants with type 1 diabetes aged 14 and older, time in range (70–180 mg/dL) reached 77% with Omnipod 6 compared with 73% using Omnipod 5.
The study also showed promising glucose outcomes while participants performed fewer manual boluses.
However, the systems were evaluated using different glucose targets. These study results do not guarantee the same outcomes for every individual.
What Is New About the STRIVE2 Trial?
In November 2026, Insulet confirmed that enrollment of the type 1 diabetes cohort in STRIVE2 had been completed.
The trial compares Omnipod 6 with Omnipod 5 in people who are not meeting their desired glucose management targets. The aim is to better understand how the next-generation algorithm performs in more challenging everyday conditions.
Insulet is also developing a separate fully closed-loop automated insulin delivery system for people with type 2 diabetes, supported by the EVOLVE study. This is a different project from Omnipod 6.
When Will Omnipod 6 Be Available?
Insulet continues to target a 2027 launch for Omnipod 6.
As of November 2026, exact commercial availability dates for individual European countries have not been confirmed. Final retail pricing and the availability of different system configurations also remain unknown.
Should Current Omnipod 5 Users Wait for Omnipod 6?
The development of a new generation does not mean current Omnipod 5 users need to stop using their existing system.
Omnipod 5 remains an established automated insulin delivery system that integrates with supported continuous glucose monitoring devices.
Diabet12 offers different versions of Omnipod 5 Pods:
- Omnipod 5 Pods compatible with Dexcom G6 and Dexcom G7.
- Omnipod 5 Pods compatible with Dexcom G6 and FreeStyle Libre 2 Plus.
Always check compatibility with your CGM sensor, controller and system version before purchasing. Compatibility between existing Omnipod 5 Pods and the future Omnipod 6 system should not be assumed.
You can also read our guide to choosing Omnipod 5 Pods for Dexcom and FreeStyle Libre.
We will continue following official Insulet announcements and sharing updates about Omnipod 6 development and availability.
Sources: Insulet announcements dated June 6 and November 4, 2026. This article is for informational purposes and does not replace medical advice. Changes to insulin therapy should be discussed with your healthcare professional.